Health Condition 1: N738- Other specified female pelvic inflammatory diseases
Conditions
Interventions
None listed
Sponsors
Rohini Ghuguskar
Dr Swathi C
Eligibility
Inclusion criteria
Inclusion criteria: Age group between 35 to 50 years Diagnosed cases of Adenomyosis with the Heavy Menstrual Bleeding and Dysmenorrhoea.
Exclusion criteria
Exclusion criteria: Use of IUCD Patient with ongoing treatment of systemic disease like diabetes, hypertension, cardiac diseases. Polyps, Leiomyoma, Malignancy and hyperplasia, Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic. Endocrinal Diseases (Hypo/ Hyper Thyroidism) Non - menstrual causes for bleeding (Foreign body, Abortion) Hb percentage less than 7 PCOS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Menstrual Bleeding: Measured as the change in the volume, duration, and frequency of menstrual bleeding. This can be assessed using a combination of patient-reported outcome measures (such as menstrual diaries or questionnaires) and clinical assessments (such as blood loss quantification and imaging studies) before and after the intervention.Timepoint: 6 days in a month for three consecutive cycles | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstrual Pain Severity: Assessment of changes in the severity of menstrual pain using a standardized pain scale (e.g., Visual Analog Scale or Numeric Rating Scale).Menstrual Bleeding: Evaluation of changes in menstrual bleeding patterns, including duration and volume of menstrual flow.Quality of Life: Measurement of improvements in overall quality of life related to symptoms of adenomyosis, using a validated quality of life questionnaire.Hormonal Profile: Analysis of hormonal changes related to adenomyosis, such as levels of estrogen and progesterone.Adverse Events: Monitoring and reporting of any adverse events or side effects associated with the treatment.Patient Satisfaction: Assessment of patient satisfaction with the treatment regimen and perceived improvements in symptoms.Uterine Size: Measurement of changes in uterine size through imaging techniques such as ultrasound or MRI.Timepoint: 6 days in a month for three consecutive cycles | — |
Countries
India
Contacts
Public ContactGhuguskar Rohini Nilkanth
Sri Jayendra Saraswathi Ayurveda College and Hospital, Chennai
Outcome results
None listed